HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4,5-diaminopentanoic acid (DAVA)

structure given in first source; RN given is for parent cpd without isomeric designation
Also Known As:
DAVA; 4,5-diaminopentanoic acid dihydrochloride; 4,5-diaminopentanoic acid dihydrochloride, (S)-isomer; 4,5-diaminopentanoic acid, (S)-isomer; 4,5-diaminovaleric acid
Networked: 6 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ding, X: 1 article (06/2017)
2. Wang, C W: 1 article (06/2017)
3. Wang, L L: 1 article (06/2017)
4. Wang, X F: 1 article (06/2017)
5. Wang, Z G: 1 article (06/2017)
6. Zang, Y Z: 1 article (06/2017)
7. Arunachalam, Sankarganesh: 1 article (01/2012)
8. Hwang, Pyoung Han: 1 article (01/2012)
9. Kim, Min Sun: 1 article (01/2012)
10. Kim, Sun Young: 1 article (01/2012)

Related Diseases

1. Cardiomyopathies (Cardiomyopathy)
2. Cardiotoxicity
3. Staphylococcal Infections
4. Seizures (Absence Seizure)
5. Pica (Geophagia)
06/20/2017 - "目的: 探讨椎动脉夹层动脉瘤(DAVA)的分型及血管内技术治疗策略。 方法: 回顾性分析山东大学第二医院神经外科2007年1月至2016年9月采用血管内技术治疗39例DAVA患者的临床资料。根据动脉瘤与小脑后下动脉(PICA)的位置关系分为3型:PICA前型(16例)、PICA中型(9例)和PICA后型(14例);根据对侧椎动脉的血供代偿情况分为代偿型(22例)和非代偿型(17例)。根据上述分型,结合动脉瘤形态及发病形式,综合分析后选择不同的重建性手术或破坏性手术。重建性手术包括支架辅助微弹簧圈栓塞术和单纯支架置入术,破坏性手术采取动脉瘤+载瘤动脉近端栓塞术(CE+PT)。 结果: PICA前型16例,其中代偿型9例,4例行CE+PT,5例行支架辅助微弹簧圈栓塞术(stent/coils);非代偿型7例,6例行stent/coils,1例行单纯支架置入术(stents)。PICA中型9例,其中代偿型5例,均行stent/coils,非代偿型4例,2例行stent/coils,2例行stents。PICA后型14例,其中代偿型8例,6例行CE+PT,1例行stent/coils,1例行stents;非代偿型6例,4例行stent/coils,2例行stents。共有10例行CE+PT,23例行stent/coils,6例行stents。围手术期死亡2例,重度残疾1例,围手术期并发症发生率和死亡率分别为7.7%(3/39)和5.1%(2/39);36例患者长期随访显示一次治疗完全栓塞率为77.8%(28/36),长期随访mRS评分:0~2分36例(92.3%),3~6分3例(7.7%)。 结论: 基于DAVA与PICA的位置关系、血流动力学、形态学及发病方式而进行的分型对指导血管内治疗方式的选择是安全有效的。."

Related Drugs and Biologics

1. Pentylenetetrazole (Metrazol)
2. gamma-Aminobutyric Acid (GABA)
3. Protective Agents
4. GABA Agonists (GABA Receptor Agonists)
5. GABA Receptors (GABA Receptor)
6. Aminocaproic Acid (6 Aminocaproic Acid)
7. Tranexamic Acid (AMCA)
8. Taurine
9. Picrotoxin
10. Cysteic Acid

Related Therapies and Procedures

1. Stents
2. Induced Hypothermia